Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oric Pharmaceuticals (ORIC) Prepaid Assets (2019 - 2026)

Oric Pharmaceuticals filings provide 8 years of Prepaid Assets readings, the most recent being $8.3 million for Q1 2026.

  • Quarterly Prepaid Assets rose 7.67% to $8.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.3 million through Mar 2026, up 7.67% year-over-year, with the annual reading at $7.0 million for FY2025, 10.94% up from the prior year.
  • Prepaid Assets hit $8.3 million in Q1 2026 for Oric Pharmaceuticals, up from $7.0 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $8.6 million in Q2 2025 and bottomed at $3.5 million in Q1 2023.
  • Average Prepaid Assets over 5 years is $6.2 million, with a median of $6.5 million recorded in 2022.
  • The largest annual shift saw Prepaid Assets surged 127.7% in 2022 before it plummeted 35.02% in 2023.
  • Oric Pharmaceuticals' Prepaid Assets stood at $4.2 million in 2022, then increased by 5.38% to $4.4 million in 2023, then soared by 42.63% to $6.3 million in 2024, then grew by 10.94% to $7.0 million in 2025, then increased by 18.96% to $8.3 million in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Prepaid Assets are $8.3 million (Q1 2026), $7.0 million (Q4 2025), and $8.5 million (Q3 2025).